Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Mar 01, 2021 4:08pm
86 Views
Post# 32687843

RE:RE:RE:RE:RE:RE:RE:RE:RE:Just thought I would pass this along

RE:RE:RE:RE:RE:RE:RE:RE:RE:Just thought I would pass this alongLike you said it's important the company shows not by words but actions they value long term investors, the lucrative deal being awarded to new investors followed by options granted to the board members isn't exactly what I would call valuing your investors.
 
scarlet1967 wrote: I believe both the CMO and CEO done a great job so far but looking at the SP in the last few years I still think a public company should first make sure their embattled investors get taken care of before their employees.

SPCEO1 wrote: I would be happy to give Christian Marsolais another huge option grant this year. He has really done the job for shareholders. 

scarlet1967 wrote:

How can anyone who has been holding this company's shares for the last decade defend granting options to board members/management.
They just started to support the SP by decent marketing but we long term investors are still the big loosers in the middle of one of the longest bull markets in the history of bull markets. It's about time for the company to take care of their investors rather than rewarding themselves.

 

 

SPCEO1 wrote: The other option from selling the stock and moving on is to vote against some or all of the board. We are the bosses here, not them. If they abuse the confidence we have placed in them you do not need to sell and run away - you can send them away. Which makes much more sense in this case since the outlook for the company is very intriguing.

Since the voting does not take place for some time, it is good not to do what foolish shareholders have done time and time again over the years and forget what happened or not utilize their vote to send the proper message to the leadership team who is filling their own pockets with options, giving johnny come lately shareholders outrageously attractive warrants and leaving loyal legach sharehodlers with less than 70% of what they used to have. Because shareholders almost always forget how leadership took advantage of them and/or because they fail to exercise the vote they are entitled to, company managements are empowered to keep kicking them in the head without consequence. JFM1330 - I have never thought you were so foolish as to ignore the reality of what was done to us with that offering (and you in particular since you had just reentered the stock immediately before the offering). You shoyld be more righteously indignant than any of us!  

As I have stated several times, TH's leadership team seems like a nice group of people who are generally sensible. They put together quite a bit out of next to nothing and deserve credit for that. But they failed miserably in converting their success into shareholder success and then massively compunded that error with an atrocious offering. At some point, we shareholders need to hold them to account. If I do vote against the board at the AGM, I will not be happy doing so. I will only do so because it seems abslutely foolish to not vote against people who made two huge mistakes (not translating their remarkable operational success into share price success in the middle of a big bull market and the odious offering whereby they stabbed loyal shareholders in the back while lining their own pockets and those of newby shareholders) that have cost my clients a ton of money.

I mean really, how can you ignore these obvious facts and not take action? If youahve a good argument that defends TH's leadership, I am all ears as I don't like having to point this stuff out or having to vote against the board, but it seems like anyone trying to defend the indefensible has a hard road ahead of them, 
 

 

jfm1330 wrote: I am tired of reading about anger, frustration or indignation about the last financing. What's the point of repeating it over and over? Hey! We know it! If someone thinks the BOD and management are crooks and/or a bunch of incompetents, just sell the stock and move on.

If Thera is going to finally be a success story, this financing will only be one event in a serie of events, some totally in favor of the company, and other less so, like this financing. If oncology ends up as a blockbuster, imagine how good a deal for shareholders it will have been, same for NASH. The company got both for almost nothing. They got Trogarzo's rights for almost nothing upfront.

Also, the worst thing for somebody taking an insurance policy, is to say it was a bad move at the end of it because you did not need to use it.

 

 

 




<< Previous
Bullboard Posts
Next >>